RPG Life Sciences Ltd.

1530.00 +57.50 ▲3.9%

28 March 2024, 04:01:00 PM
Volume: 570

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.rpglifesciences.com
Market Cap 2,530.80 Cr.
Enterprise Value(EV) 2,507.79 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 51.25 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 29.85 Trailing Twelve Months Ending 2023-12
Industry PE 41.54 Trailing Twelve Months Ending 2023-12
Book Value / Share 219.00 Trailing Twelve Months Ending 2023-12
Price to Book Value 6.99 Calculated using Price: 1,530.20
Dividend Yield 0.78 Period Ending 2023-03
No. of Shares Subscribed 1.65 Cr. 16,539,015 Shares
FaceValue 8
About RPG Life Sciences Ltd.
RPG Life Sciences (RPGLS) is a pharmaceutical organization and was formerly known as Searle (India) Limited. It is a full spectrum world class, customer focussed, innovative pharmaceutical organisation. RPGLS started in 1968 as a joint venture with GD Searle, USA. In 1993, GD Searle withdrew from India and sold its holdings to the RPG Group. The company's name was changed to RPG Life Sciences Ltd effective April 1, 1999.This company belongs to RPG group

RPG Life Sciences Ltd. Delivery

Delivered Qty
Traded Qty

RPG Life Sciences Ltd. Performance

1 Day
+3.90%
1 Week
+2.00%
1 Month
-2.11%
3 Month
+12.14%
6 Month
+16.43%
1 Year
+117.14%
2 Year
+165.90%
5 Year
+513.84%
10 Year
+2531.13%

RPG Life Sciences Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 0.8 8.98 14.98 8.91 6.86 17.21 20.36 21.8 24.01
Return on Capital Employed (%) 2.5 8.97 15.58 12.52 9.81 20.35 27.27 31.46 32.92
Return on Assets (%) 0.47 5.34 9.15 5.17 4.07 11.25 14 15.89 17.71

RPG Life Sciences Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 125 134 147 155 161 177 216 256 308 336
Non Curr. Liab. 20 22 11 8 10 9 7 9 9 8
Curr. Liab. 67 67 79 121 78 83 80 80 103 117
Minority Int.
Equity & Liab. 212 223 236 284 248 268 303 345 419 461
Non Curr. Assets 126 136 140 141 151 142 127 138 155 181
Curr. Assets 86 87 96 143 97 126 176 207 264 280
Misc. Exp. not W/O
Total Assets 212 223 236 284 248 268 303 345 419 461

RPG Life Sciences Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 242 279 294 344 330 376 389 440 513 574
Other Income 7 2 10 2 1 1 1 3 5 7
Total Income 249 281 303 346 331 377 390 443 518 581
Total Expenditure -234 -257 -265 -307 -296 -316 -318 -353 -409 -450
PBIDT 15 24 38 39 35 61 72 90 108 131
Interest -3 -2 -4 -5 -5 -3 -2 -1 -1 0
Depreciation -11 -10 -11 -14 -15 -16 -16 -16 -15 -16
Taxation -2 -7 -4 -7 -14 -22 -24 -29
Exceptional Items -5
PAT 1 12 21 13 11 29 40 51 68 85
Adjusted EPS 1 7 13 8 7 18 24 31 41 51

RPG Life Sciences Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. -6 -2 33 7 15 46 50 58 65 91
Cash Fr. Inv. 59 -10 -15 -30 -16 -19 -11 -8 -35 -106
Cash Fr. Finan. -54 12 -18 23 0 -27 -39 -10 -14 -17
Net Change 0 0 0 1 -1 0 0 40 17 -32
Cash & Cash Eqvt 0 0 0 1 0 0 1 40 57 25

RPG Life Sciences Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 72.07 72.07 72.41 72.61 72.61 72.81 72.81 72.81 72.81
Public 27.93 27.93 27.59 27.39 27.39 27.19 27.19 27.19 27.19
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

RPG Life Sciences Ltd. Announcements

Wed, 27 Mar 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find attached herewith Loss of share certificate intimation received from the Registrar and share transfer agent dated March 27 2024. Kindly take the same on record
Tue, 26 Mar 2024
Closure of Trading Window
Company has informed about Trading Window Closure pursuant to SEBI(Prohibition of Insider Trading) Regulation 2015.
Mon, 11 Mar 2024
Agreement For Subscription To Shares
Execution of Share Subscription and Shareholders Agreement with Sunpound Solar Private Limited (Sunpound) Special Purpose Vehicle (SPV) for subscribing to at least 26% of the issued and paid up equity share capital of Sunpound in proportionate to the contracted capacity of corresponding captive generating power plant for value not exceeding Rs.1.10 crore.Details as per SEBI Circular dated July 13 2023 are enclosed as Annexure A.Kindly take the same on record.

RPG Life Sciences Ltd. Technical Scans

Thu, 28 Mar 2024
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
Closing Above Previous High Closing Above Previous High
Close Within 52 Week High Zone Close Within 52 Week High Zone
Close Entering 52 Week High Zone Close Entering 52 Week High Zone
Making Higher Highs for 2 Days Making Higher Highs for 2 Days

RPG Life Sciences Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 388,812.23 1,620.50 +0.8%
Cipla Ltd. 120,673.12 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. 102,679.14 6,171.85 +2.0%
Zydus Lifesciences Ltd. 101,151.67 1,007.35 +0.8%
Mankind Pharma Ltd. 92,029.19 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. 91,330.58 6,347.35 +1.9%
Divi's Laboratories Ltd. 91,234.91 3,452.55 +2.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 43.66 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-12 32.54 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.64 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 34.01 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-12 53.29 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 115.71 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-12 65.97 3,452.55 +2.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 6.23 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-12 4.66 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.82 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.37 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-12 10.36 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.52 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-12 7.00 3,452.55 +2.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 0.02 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,452.55 +2.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 12.85 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,452.55 +2.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 12.85 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,452.55 +2.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,452.55 +2.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,452.55 +2.6%

RPG Life Sciences Ltd. FAQ's

What is RPG Life Sciences share price?

Can I buy RPG Life Sciences shares now?

What is the Dividend Yield of RPG Life Sciences?

What is the Market Cap of RPG Life Sciences?

What are the key metrics to analyse RPG Life Sciences?

What is the 52 Week High and Low of RPG Life Sciences?

What is the trend of RPG Life Sciences share price?